Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Osteosarcoma × apatinib × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 2 Osteosarcoma 1 Neoplasm Metastasis 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Doxorubicin 2 apatinib 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Methotrexate 1 Ifosfamide 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Peking University People's Hospital

Phase 2/3 Completed

Neoplasm Metastasis, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡